“Multi-Targeted Tyrosine Kinase Inhibitor Sorafenib. Application Experience in Kidney Cancer With Lung Metastases”. 2016. Voprosy Onkologii 62 (1): 154-56. https://doi.org/10.37469/0507-3758-2016-62-1-154-156.